Compare Stocks: ARAY, MBOT, KEQU, and LNSR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARAY Accuray	$0.23 -3.1%	$0.27	$0.22 ▼ $2.10	$27.90M	1.39	415,617 shs	508,549 shs
KEQU Kewaunee Scientific	$34.11 -5.5%	$36.56	$32.00 ▼ $46.57	$98.76M	0.73	2,792 shs	28,762 shs
LNSR LENSAR	$7.07 -0.3%	$7.05	$4.95 ▼ $12.94	$86.86M	0.97	90,057 shs	124,413 shs
MBOT Microbot Medical	$1.36 -4.2%	$1.62	$1.35 ▼ $3.74	$91.34M	1.03	443,395 shs	686,319 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARAY Accuray	0.00%	-6.63%	-20.11%	-32.85%	-85.31%
KEQU Kewaunee Scientific	0.00%	-5.31%	-6.47%	-9.11%	-24.62%
LNSR LENSAR	0.00%	-6.97%	-16.23%	+23.17%	-44.20%
MBOT Microbot Medical	0.00%	-6.21%	-8.72%	-26.88%	-59.04%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARAY Accuray	$0.23 -3.1%	$0.27	$0.22 ▼ $2.10	$27.90M	1.39	415,617 shs	508,549 shs
KEQU Kewaunee Scientific	$34.11 -5.5%	$36.56	$32.00 ▼ $46.57	$98.76M	0.73	2,792 shs	28,762 shs
LNSR LENSAR	$7.07 -0.3%	$7.05	$4.95 ▼ $12.94	$86.86M	0.97	90,057 shs	124,413 shs
MBOT Microbot Medical	$1.36 -4.2%	$1.62	$1.35 ▼ $3.74	$91.34M	1.03	443,395 shs	686,319 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARAY Accuray	0.00%	-6.63%	-20.11%	-32.85%	-85.31%
KEQU Kewaunee Scientific	0.00%	-5.31%	-6.47%	-9.11%	-24.62%
LNSR LENSAR	0.00%	-6.97%	-16.23%	+23.17%	-44.20%
MBOT Microbot Medical	0.00%	-6.21%	-8.72%	-26.88%	-59.04%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARAY Accuray	1.67	Reduce	$2.00	756.16% Upside
KEQU Kewaunee Scientific	2.00	Hold	N/A	N/A
LNSR LENSAR	2.33	Hold	$11.50	62.66% Upside
MBOT Microbot Medical	2.40	Hold	$6.38	368.75% Upside

Current Analyst Ratings Breakdown

Latest ARAY, MBOT, KEQU, and LNSR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/11/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$4.00
9/1/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/21/2026	LNSR LENSAR	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/20/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$9.00 ➝ $10.00
8/20/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00 ➝ $4.00
8/13/2026	LNSR LENSAR	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
8/13/2026	LNSR LENSAR	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $9.00
8/7/2026	LNSR LENSAR	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/4/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARAY Accuray	$401.95M	0.07	N/A	N/A	$0.35 per share	0.67
KEQU Kewaunee Scientific	$282M	0.35	$5.95 per share	5.73	$26.67 per share	1.28
LNSR LENSAR	$58.44M	1.49	N/A	N/A	($2.18) per share	-3.24
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$1.15 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARAY Accuray	-$49.19M	-$0.40	N/A	N/A	N/A	-12.24%	-97.85%	-10.82%	11/4/2026 (Estimated)
KEQU Kewaunee Scientific	$9.62M	$2.76	12.36	N/A	N/A	2.97%	11.61%	4.82%	N/A
LNSR LENSAR	-$34.28M	-$0.33	N/A	N/A	N/A	57.57%	-529.08%	50.03%	11/12/2026 (Estimated)
MBOT Microbot Medical	-$13.14M	-$0.24	N/A	N/A	N/A	N/A	-21.87%	-20.76%	11/11/2026 (Estimated)

Latest ARAY, MBOT, KEQU, and LNSR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2026	Q1 2027	KEQU Kewaunee Scientific	N/A	$0.58	N/A	$0.58	N/A	$66.32 million
8/19/2026	Q4 2026	ARAY Accuray	-$0.03	-$0.02	+$0.01	-$0.02	$105.30 million	$100.92 million
8/13/2026	Q2 2026	LNSR LENSAR	-$0.1650	$0.10	+$0.2650	$0.10	$14.65 million	$16.50 million
8/11/2026	Q2 2026	MBOT Microbot Medical	-$0.0767	-$0.08	-$0.0033	-$0.08	$0.13 million	$0.24 million
6/23/2026	Q4 2026	KEQU Kewaunee Scientific	N/A	$1.14	N/A	$1.13	N/A	$71.40 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARAY Accuray	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARAY Accuray	3.51	1.50	0.74
KEQU Kewaunee Scientific	0.51	2.20	1.55
LNSR LENSAR	N/A	2.39	1.13
MBOT Microbot Medical	N/A	18.56	17.82

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARAY Accuray	64.08%
KEQU Kewaunee Scientific	32.69%
LNSR LENSAR	40.15%
MBOT Microbot Medical	16.30%

Insider Ownership

Company	Insider Ownership
ARAY Accuray	2.40%
KEQU Kewaunee Scientific	14.10%
LNSR LENSAR	65.80%
MBOT Microbot Medical	4.74%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARAY Accuray	809	119.44 million	116.57 million	Optionable
KEQU Kewaunee Scientific	1,231	2.90 million	2.49 million	Not Optionable
LNSR LENSAR	150	12.29 million	4.20 million	Optionable
MBOT Microbot Medical	22	67.17 million	63.98 million	Optionable

ARAY, MBOT, KEQU, and LNSR Headlines

Recent News About These Companies

Microbot Medical stock gains analyst upgrade while fundamentals remain in focus

September 19 at 11:29 PM | ad-hoc-news.deA

Microbot Medical (NASDAQ:MBOT) Raised to "Sell" at Wall Street Zen

September 19 at 1:30 AM | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Raised to Sell at Wall Street Zen

September 19 at 1:29 AM | marketbeat.com

B. Riley Financial Begins Coverage on Microbot Medical (NASDAQ:MBOT)

September 13, 2026 | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Coverage Initiated at B. Riley Financial

September 11, 2026 | marketbeat.com

Wall Street Zen Downgrades Microbot Medical (NASDAQ:MBOT) to Strong Sell

September 5, 2026 | marketbeat.com

Microbot Medical Inc. (NASDAQ:MBOT) Receives Average Rating of "Hold" from Analysts

August 29, 2026 | marketbeat.com

Microbot Medical (NASDAQ:MBOT) Lowered to "Hold" Rating by Zacks Research

August 22, 2026 | marketbeat.com

HC Wainwright Lowers Earnings Estimates for Microbot Medical

August 21, 2026 | marketbeat.com

Microbot Medical Inc.: Microbot Medical Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | finanznachrichten.de

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | markets.businessinsider.com

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2026 | zacks.com

New Strong Buy Stocks for July 23rd

July 23, 2026 | zacks.com

Microbot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual Meeting

July 21, 2026 | quiverquant.comQ

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting

July 21, 2026 | globenewswire.com

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

July 7, 2026 | globenewswire.com

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

June 30, 2026 | globenewswire.com

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

June 25, 2026 | globenewswire.com

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

June 23, 2026 | globenewswire.com

Microbot Medical Expands Federal Access for LIBERTY Robotics

June 17, 2026 | theglobeandmail.com

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

June 16, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARAY, MBOT, KEQU, and LNSR Company Descriptions

Accuray NASDAQ:ARAY

$0.23 -0.01 (-3.07%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.24 +0.01 (+3.17%)

As of 09/18/2026 06:59 PM Eastern

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Kewaunee Scientific NASDAQ:KEQU

$34.11 -2.00 (-5.54%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$34.94 +0.83 (+2.42%)

As of 09/18/2026 04:10 PM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

LENSAR NASDAQ:LNSR

$7.07 -0.02 (-0.28%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$7.07 0.00 (0.00%)

As of 09/18/2026 04:10 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Microbot Medical NASDAQ:MBOT

$1.36 -0.06 (-4.23%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$1.38 +0.01 (+1.10%)

As of 09/18/2026 07:58 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ARAY, MBOT, KEQU, and LNSR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ARAY, MBOT, KEQU, and LNSR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ARAY, MBOT, KEQU, and LNSR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARAY, MBOT, KEQU, and LNSR Company Descriptions

Accuray NASDAQ:ARAY

Kewaunee Scientific NASDAQ:KEQU

LENSAR NASDAQ:LNSR

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ARAY, MBOT, KEQU, and LNSR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ARAY, MBOT, KEQU, and LNSR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ARAY, MBOT, KEQU, and LNSR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARAY, MBOT, KEQU, and LNSR Company Descriptions

Accuray NASDAQ:ARAY

Kewaunee Scientific NASDAQ:KEQU

LENSAR NASDAQ:LNSR

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools